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Rab proteins are small GTPases involved in the regulation of vesicular membrane traffic. Research done in the past years has
demonstrated that some of these proteins are under the control of signal transduction pathways. Still, several recent papers point out to a new
unexpected role for this family of Ras-related proteins, as potential regulators of intracellular signaling pathways. In particular, several
evidence indicate that members of the Rab family of small GTPases, through their effectors, are key molecules participating to the regulation
of numerous signal transduction pathways profoundly influencing cell proliferation, cell nutrition, innate immune response, fragmentation of
compartments during mitosis and apoptosis. Even more surprisingly, direct involvement of Rab proteins in signaling to the nucleus has been
demonstrated. This review will focus on aspects of Rab proteins function connected to signal transduction and, in particular, connections
between membrane traffic and other cell pathways will be examined.
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E-mail address: cecilia.bucci@unile.it (C. Bucci).transport of lipids, protein and particulate matter is regulated.
In particular, it is becoming clear how cargo is selected in the
appropriate vesicle and how vesicles recognize and fuse with
the appropriate compartment [1–3].
The Rab family of small GTPases is heavily involved in
the regulation of vesicular transport [4,5]. Indeed, Rab
GTPases are key regulatory molecules that control mem-18 (2006) 1 – 8
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contain more than 60 Rab proteins that are localized to
distinct vesicular compartments and regulate specific steps of
membrane transport. Rab proteins recruit on membrane one
or more effector proteins that mediate formation of transport
vesicles, tethering and docking of vesicles, motor protein-
dependent movement therefore facilitating ultimate fusion
between membrane compartments (see [6–8] for review).
Recently, several studies have demonstrated a close
connection between membrane traffic and signal trans-
duction [9–11]. Signal transduction pathways direct a
variety of cellular processes, including gene expression
(through the action of more than 2000 transcription factors
encoded by the human genome), cell survival, cell growth,
differentiation, proliferation, cell cycle, apoptosis and
several other fundamental cellular events [12].
Lately, a close connection between Rab proteins function
and signal transduction pathways has been revealed. In this
review we will focus on aspects of signaling pathways that
involve, directly or indirectly, Rab proteins.2. Phosphoinositide kinases
All eukaryotic cells, from yeast to mammals, contain
phoshoinositides, which are formed from phosphorylation of
the head group of phosphatidylinositol (PtdIns). The
enzymes responsible for these reactions are termed phos-
phoinositide kinases and, through the formation of phoshoi-
nositides, they control cellular processes as important as
proliferation, survival, cytoskeletal organization, vesicle
trafficking, glucose transport and platelet function. Phos-
phoinositide kinases are usually divided in three families:
phosphoinositide 3-kinase (PI3K), PtdIns 4-kinases
(PtdIns4Ks) and PtdIns-P (PIP) kinases (PIP5Ks) [13]. The
localization of these kinases and of the corresponding PtdIns
phosphatases leads to the precise distribution of the individ-
ual PtdIns species in different subcellular compartments.
Proteins containing PtdIns-binding motifs, among which the
FYVE, PhoX homology, pleckstrin homology, ENTH and
ANTH domains, ultimately localize to the corresponding
membrane domains where they exert their different functions.
Among the different families, PI3Ks have been partic-
ularly well studied for their initial involvement in the control
of cellular growth and apoptosis and, more recently, in key
steps of membrane trafficking. It is therefore not surprising a
cross-talk between Rab GTPases and members of the PI3K
family of proteins. Indeed, Rab5 appears to be important for
the recruitment of hVPS34/p150, a class III PI3K, to the early
endosomes, through its GTP-dependent interaction with
p150 [14]. Consequently, PtdIns(3)P, a privileged product
of hVPS34/p150, is found at high levels in the membrane of
these structures [15,16], recruiting FYVE and PhoX domain-
containing proteins such as the Rab5 effectors EE1A,
Rabenosyn-5, Rabip4V and the kinesin KIN16B [17–20]
which participate both in the basic vesicle formation processand in the intracellular movement of these organelles. More
recently, also Rab7 has been identified as as an important
regulator of late endosomal hVPS34 function [21], suggest-
ing this kinase as a key player of vesicle maturation between
early and late endosomes.
Rab5 has represented the first example of a protein of the
Rab family directly interacting with a class I PI3K, p85a/
p110h [22], consisting of a catalytic p110 isoform asso-
ciated with a regulatory subunit, p85a. As this PI3K is
profoundly involved in signaling controlling cellular growth
and survival, its interaction with Rab5 may suggest a role
for this Rab GTPase also in these processes. Indeed, several
observations already support this suggestion. Not only Rab5
interacts with p85a/p110h but also leads to efficient
coupling of the lipid kinase product to one of its most
important downstream targets for what concerns cell
survival, Akt [23]. Similarly, Rab4, a Rab protein involved
in insulin action, controls PI3K and Akt activation [24].
Last, recent studies implicated Rab25 in aggressiveness of
epithelial cancers, possibly through the activation of the
PI3K/Akt pathway [25]. Indeed, high-density array com-
parative genomic hybridization (CGH) showed amplifica-
tion of an area of chromosome 1q22 where Rab25 is
localized, in approximately half of ovarian and breast
cancers. Increased levels of the GTPase were also associated
with decreased survival in these types of cancers [25]. As
concerns the mechanism mediating Rab25 effects on tumor
aggressiveness, the inhibition of apoptosis was associated
with a decrease in expression of the proapoptotic molecules,
BAK and BAX, and activation of the antiapoptotic PI3K
and Akt pathway [25]. In line with a potential involvement
of Rab proteins in the control of cell proliferation and
survival, forced expression of Rab25 also markedly
increased anchorage-dependent and anchorage-independent
cell proliferation, prevented apoptosis and anoikis, including
that induced by chemotherapy, and increased aggressiveness
of cancer cells in vivo [25].
The identification of the physical and functional link
between Rab proteins and PI3Ks has nonetheless revealed an
extraordinary complexity of the reciprocal regulation of
these proteins on one another. Based on current knowledge,
it is in fact possible to consider these proteins as inserted in
an auto-regulatory loop in which, once activated by tyrosine
kinase receptor such as the one for EGF [26], Rab5 stimulate
PI3K, whose p85 regulatory subunit acts as a GAP on Rab4
and Rab5 itself, therefore regulating how long these GTPases
remain in their GTP-bound active state [27]. It is important to
note however that these effects may depend on the specific
receptor and system used as, for example, in rat adipocytes,
insulin stimulates the guanine-nucleotide exchange activity
of Rab4, via a PI3K-dependent signaling pathway [28].
The prototype PtdIns4Ks were first cloned from yeast
and designated PIK1 [29] and STT4 [30]. Subsequently,
cDNAs for two mammalian PtdIns4Ks were cloned and
termed PI4Ka and PI4Kh. The latter is present in the
cytoplasm where it is concentrated in the Golgi complex
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been recently characterized as regulators of Rab-dependent
signaling pathways, both in mammalians and in yeast
[32,33]. Indeed, as in the case of PI3Ks, also PI4Ks interact
with at least one Rab family protein, Rab11, which is
recruited to the Golgi complex using PI4Kh as a docking
factor anchored to this structure [32].3. Germinal center kinases
Germinal center kinases (GCKs) are recruited to the
membrane by either receptor tyrosine kinases (RTK) or
activated components of TNF-Receptors family of proteins.
Recruitment is followed by activation of the kinase activity
of GCK. Stimuli that recruit the GCKs to the membrane
may also recruit upstream components of MAP kinase
modules, which represent GCKs targets, specifically acti-
vating the JNK pathway [34]. The GCKs represent therefore
an emerging family of protein kinases that regulate
eukaryotic stress responses. A member of this family of
kinases has been identified as a Rab8 interacting protein
(Rab8ip), possibly representing an effector for this GTPase
as it specifically interacts with its GTP-loaded form [35].
Therefore, although Rab8-GCK interaction may represent a
way for the cell to bridge cellular stress responses to
vesicular traffic, it is also possible to speculate that Rab8
may participate in the activation of a stress-activated MAP
kinase signaling pathway and, in turn, directly regulate JNK
activation and, possibly, cell survival and apoptosis.
Although more definitive data are awaited to support such
a hypothesis, recent information suggest a direct role for
Rab proteins in the control of cellular apoptosis. Indeed, in a
stressful condition such as growth factor withdrawal, Rab7
has been demonstrated to function as a pro-apoptotic
protein, a dominant negative Rab7 even cooperating with
the E1A oncogene in classical transformation assays [36].4. Protein kinase A (PKA)
G protein-coupled receptors (GPCRs) regulate the
activity of various isoforms of adenylyl cyclase, leading to
generation of cAMP. In turn, although different effectors of
cAMP have been identified, the most common is PKA.
Once activated, the cAMP-PKA pathway controls cell
functions as different as cell cycle, proliferation, differ-
entiation, regulation of microtubule dynamics, chromatin
condensation and decondensation, nuclear envelope disas-
sembly and reassembly, intracellular transport, ion fluxes,
exocytotic events in polarized epithelial cells, signaling in
the cardiovascular system and in adipose tissue, steroido-
genesis and reproductive function, modulation of immune
responses and a number of other effects elicited by
hormones, neurotransmitters, and various paracrine ligands
[37]. To provide specificity at the intracellular level andthereby convey tissue- and organ-specific effects, cAMP
generation and degradation is regulated by the adenylyl
cyclase and phosphodiesterase families of enzymes, respec-
tively [38,39]. A kinase anchoring proteins (AKAPs) further
contribute to this specificity by binding to PKA through a
PKA-binding tethering domain and targeting the enzyme to
defined subcellular structures, membranes, or organelles
[37]. In addition, several AKAPs are also able to form
multivalent signal transduction complexes by interaction
with phosphatases as well as other kinases and proteins
involved in signal transduction [37]. Two mechanisms have
been recently proposed which involve Rab proteins in the
control of PKA activity and, in turn, cellular functions. The
active, GTP-loaded form of Rab13 is in fact able to directly
bind and inhibit the activity of PKA [40]. In this
perspective, PKA therefore represents an effector of this
GTPase. Also, a PKA isoform binds to the conserved a5-
helix of Rab32, which mediates its targeting to mitochondria
and involvement in the regulation of mitochondrial fission,
therefore functioning as an AKAP in vivo [41]. Interest-
ingly, this is not the only case in which a small GTPase
participate to a complex containing PKA [42,43]. Unsus-
pected roles may, therefore, be next unraveled for these
complexes, reciprocally coordinating the functions of both
PKA and small GTPases, not only for what concerns
vesicular trafficking but also signaling in general.5. Protein kinase C (PKC)
Based on in vivo and tissue culture experiments using
phorbol esters as general PKC agonists, PKCs have long
been implicated in cell proliferation, survival, and pro-
grammed death [44]. There are at least 12 different isoforms
of PKC, commonly classified in three subgroups, and the
multiplicity of family members produces varies cellular
responses depending upon isoform activity and physiolog-
ical context. The conventional isoforms, cPKCs (PKCa,
PKCh and PKCg), are diacylglycerol (DAG) sensitive and
calcium responsive. The novel isoforms, nPKCs (PKCy,
PKCe, PKCD and PKCu), are DAG sensitive but calcium
insensitive. The atypical isoforms, aPKCs (PKC~ and
PKCL/E) have altered C1 domains and are not DAG
sensitive [45].
Activation of PKC typically involves allosteric effects of
interacting lipids/proteins on the different PKC isoforms,
leading to a loss of the inhibition exerted by the inhibitory
pseudosubstrate sequence that otherwise occupies the active
site. All the PKC family members also require phosphor-
ylation in their activation loops [46], catalysed by phos-
phoinositide-dependent kinase 1 (PDK1), which is itself
recruited to membranes by PI3K-generated PtdIns(3)P. PKC
function can be restricted to multiple compartments,
including the plasma membrane, endosomes, the Golgi
and the nucleus. Location is determined in part by the
scaffolding proteins that may themselves represent PKC
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localization sequences specific for each isoform.
Rab2 is required for membrane transport in the early
secretory pathway and localizes to vesicular tubular clusters
(VTCs) that function as transport intermediates between the
endoplasmic reticulum and the Golgi complex and represent
the first site for segregation of the anterograde and
retrograde pathways [47]. After the initial observation that
Rab2 required protein kinase C (PKC) or a PKC-like
protein to recruit h-COP to membrane [48], a role for the
aPKC, PKCL/E, was established in promoting the recruit-
ment of COPI to generate retrograde-transport vesicles [49].
Next, Rab2 was shown to directly bind PKCL/E and inhibit
PKCL/E activity, as scored by phosphorylation of glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) [50], a
PKCL/E substrate [51].
These observations have several implications. As differ-
ent binding proteins mediate PKC localization, PKCL/E
binding to Rab2 would explain why this aPKC is recruited
to the VTC structures containing this GTPase, ensuring
that the kinase is associated with Rab2 to regulate a
transport-related event through phosphorylation. Also, as
membrane-associated GAPDH is required for transport in
the early secretory pathway these findings also imply that,
through this interaction, PKCL/E participate in Rab2-
dependent control of vesicle trafficking. Finally, through
modulation of PKCL/E activity and of its downstream
signaling functions, Rab2 may directly control cell
proliferation, differentiation, and survival as well as
cytoprotection against drug-or UV-induced apoptosis, all
well known functions of this atypical PKC [52]. The
possibility of a direct influence of Rab2 and other related
GTPases on cell decisions to live or die through the
control of the activity of this kinase will therefore warrant
further investigation.6. Histone modification and nucleosome remodeling
Global or promoter-specific modifications of chromatin
structure are controlled by a large number of enzymes,
whose nature is currently deeply investigated [53]. The
MeCP1 complex, including methyl-CpG-binding protein
such as MBD2 and components of the NuRD (Nucleosome
Remodeling and histone Deacetylase) is able to bind,
remodel, and deacetylate methylated nucleosomes and,
through these mechanisms, repress transcription [54].
Accumulating evidences indicate that such protein complex
may control gene expression through the interaction with
specific transcription factors [54].
Novel putative effector partners for Rab5 have been
recently identified, APPL1 and APPL2 [55]. APPL1 has
been shown to bind GTP-loaded Rab5 on a sub-population
of early endosomes and, upon engagement with extrac-
ellular stimuli, is translocated to the nucleus where it
interacts with components of the MeCP1/NuRD complex[55]. Additionally, APPL proteins are required for cell
proliferation, as their downregulation by RNA interference
strongly affect cell cycle progression. Based on this
information, the Rab5 protein localized to endosome may
act as a key molecule integrating extracellular signals with
nuclear responses. Importantly, these data clearly differ-
entiate this pathway from other described Rab-dependent
signaling routes indirectly controlling receptor activity
through their endocytosis. Conversely, APPL1 directly
bridges GTP-bound, activated Rab5 to the control of gene
expression controlling cell proliferation [55].
The Rab5-APPL1-dependent signaling pathway also
allows suggesting new routes for investigating Rab involve-
ment in cell survival. Indeed, APPL1 has been already
shown to interact with DCC (deleted in colorectal cancer), a
candidate tumor suppressor gene, and mediate DCC-
dependent apoptosis [56]. Also, APPL1 has been implicated
in the modulation of the PI3K-Akt survival pathway [57,58]
raising the possibility of a macromolecular complex in
which Rab5 controls effectors such as PI3K and APPL1,
whose downstream activities may progress in part inde-
pendently and in part integrating for the control of cell
survival and proliferation.7. Sonic hedgehog signaling pathway
Transcriptional responses to secreted hedgehog (Hh)
protein control the development of several tissues in
organisms as different as insects and mammals. Conse-
quently, mutations in different proteins of the Hh signaling
pathway cause severe birth defects in humans, i.e.
holoprosencephaly and Gorlin’s syndrome, the latter
associated to the propensity to develop certain cancers.
Somatic mutations, in turn, have been repeatedly involved
in tumor development [59]. In the fruitfly drosophila (and
mammals share many features with this signaling path-
way), Patched (Ptc), an integral membrane protein, inhibits
Smoothened (Smo), a protein similar to GPCRs. Upon Hh
interaction with Ptc, Smo is no longer blocked and can
counteract phosphorylation by PKA, GSK3, and CKI to
prevent the processing of the Gli transcriptional regulator
through unknown mechanisms [60]. From mouse genetic,
in 2001 the first evidence for an involvement of Rab
proteins in the Hh pathway has arrived [61]. Indeed, the
Rab23 gene has been recognized as an inhibitor of the Hh
pathway, its mutant phenotype resembling those produced
by partial loss of Ptc and bypassing the recruitment for Hh
in several developmental contexts [61]. Based on the
function of Rab proteins, it has been proposed that Rab23-
dependent vesicular traffic directs components of the Hh
pathway to cellular compartments where they can be post-
transcriptionally modified. Nonetheless, members of the
Rab family have already been recently involved in the
direct binding of PKA and regulation of its activity [40].
As the cleavage of Gli proteins in mammalians is also
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inactivation by RNA interference activates the hedgehog
pathway, it is tempting to speculate a direct role of Rab
proteins in PKA-dependent phosphorylation of Gli and
control of the Hh signaling route. Whether multiple
members of the Rab family are able to modulate the Hh
pathway, possibly through PKA, remains to be determined.8. G protein-coupled receptors and tyrosine kinase
receptors
Rab proteins have finally reached recognition as signal-
ing molecules per se and not just regulators of vesicular
trafficking. Nonetheless, their ability to select proteins, such
as membrane receptors, for their subcellular localization and
destiny (i.e. degradation), has been regarded for long time as
a characteristic allowing them to control cell growth and
normal cellular homeostasis.
With more than 1000 members, the family of G protein-
coupled receptors (GPCRs) represents the largest group of
cell surface receptors. Upon activation, the seven mem-
brane-spanning regions of GPCRs undergo a dramatic
conformational change resulting in the exposure of pre-
viously masked G protein binding sites, causing the
exchange of GDP for GTP bound to the G protein a
subunit and the dissociation of Ga from the hg hetero-
dimers [63,64]. In turn, such subunits initiate intracellular
signaling responses through several different effector
molecules, including adenylyl cyclases, phosphodiesterases,
phospholipases, ion channels, ion transporters, and intra-
cellular kinases [65]. It is difficult to find an aspect of
normal cellular homeostasis whose mechanisms are not
profoundly affected by GPCRs. As expected, persistent
activation of proliferative pathways by mutated, constitu-
tively active GPCRs [66,67] can contribute to malignant
transformation, and ultimately to cancer.
GPCRs endocytosis strongly contributes to regulation of
receptor activity. Briefly, GPCRs are mostly internalized
through clathrin-coated pits, with a mechanism usually
dependent on the phosphorylation of the receptor by G
protein-coupled receptor kinases (GKRs) and h-arrestin
binding [68,69]. Once in the endosomes, receptors can be
dephosphorylated and recycled to the plasma membrane or
targeted to the late-endosomes and lysosomes where they
undergo degradation, the latter event therefore contributing
to down regulation of GPCR signaling [70]. As Rab
proteins are key regulators of multiple steps in the process
of vesicle trafficking, it is therefore not surprising that they
have been repeatedly involved the control of the internal-
ization of these receptors [71]. Most of the work
performed on the subject deals with an indirect involve-
ment of different Rab molecules in various steps of the
internalization process, according to their specific estab-
lished subcellular localization and well-known functions
[70]. Though, we like to cite work performed on theangiotensin type 1a (AT1a) receptor as it directly binds
Rab5 and stimulates its guanine nucleotide exchange
activity [72], therefore establishing also for GPCR internal-
ization a direct role for members or the Rab family of
GTPases. The possibility that AT1a and other GPCRs,
through direct interaction with Rab GTPases, not only
control their own internalization but also the previous
potentially Rab-dependent signaling pathways warrant
further investigation.
Receptor tyrosine kinases (RTKs) represent a heteroge-
neous family of transmembrane proteins with intrinsic
tyrosine kinase activity [73]. Upon binding of their cognate
ligands, they are activated through dimerization and
consequent conformational change, a process resulting in
the phosphorylation of different tyrosines which represent
docking sites for several intracellular proteins and mediate
the activation of multiple signaling pathways [73]. For
long time, initiation of RTKs signaling was a mechanism
exclusively happening on the plasma membrane, a
structure easily accessible to extracellular stimuli and
intracellular signal transducing molecules. The finding that
these receptors were internalized upon ligand binding was
immediately correlated to an attenuation and/or termination
of RTKs-mediated signals, through receptor degradation.
Still, the findings that the levels of tyrosine phosphor-
ylation of different RTKs was elevated in endosomes
opened the way to an alternative scenario in which
receptor located in the endosomes may initiate specific
signaling capacities [74].
Upon ligand engagement, multiple monoubiquitination
of the epidermal growth factor (EGF) and platelet-derived
growth factor (PDGF) receptors has been recognized as a
key event for their internalization through the endosomal
pathway and, possibly, lysosome-dependent degradation
[75]. At the same time, the EGF receptor controls the
activity of Rab5 [26,76] and, through this GTPase, the rate
of its own endocytosis [77]. Once internalized, the EGF
receptor is directed to the early endosomal compartment
that, in turn, contains several proteins acting downstream
of these receptors, being the Sos-Ras-Raf-MEK-Erk path-
way particularly represented [26,78–80]. In view of these
observations, Rab proteins could determine, among the
several potential EGF receptor downstream pathways,
which one would be preferentially activated [81]. Not
only internalization of the EGF receptor contributes to the
specificity of the downstream signaling pathways but also
to their intensity as blocking such process strongly
interfere with the activity of the Erk1/2 and PI3K cascades
[82]. This controlling mechanism, together with the duration
of the signaling output from the receptor, will therefore
determine the biological response a cell will embrace to best
adapt to the specific intra and extracellular environment (for
a more extensive review on the subject see [55]). Whether
GTPases such as Rab5 participate to cellular decisions to
proliferate or differentiate, even as a consequence of the
same stimulus, i.e. EGF, remains to be discovered.
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Besides directly controlling the activity of different
kinases, it is now clear that Rab GTPases may also represent
a class of specific substrates for these enzymes. One of the
best examples in which phosphorylation of Rab GTPases is
an important process is the control of the endosomal
compartment in specific phases of the cell cycle.
Cell cycle is usually distinguished in two phases,
interphase and mitosis. The process of mitosis leads to the
production of two independent daughter cells whose genetic
material is identical to the progenitor cell. During this process,
after the accurate partition of the chromosomes (karyokinesis),
the cell also divides its cytoplasm and organelles (cytokine-
sis). Cdk1 is the key kinase controlling the entrance into the
mitotic phase of the cell cycle but also Polo-like and MAP
kinases modulates changes in Golgi reorganization during cell
division, both in interphase and in mitosis [83].
The complete endocytic process is arrested at the onset of
mitosis [84]. Fusion events among endosomes are also
interrupted with a mechanism requiring the mitotic Cdk1
kinase [85,86]. Once cytokinesis starts, endosomes and
lysosomes are partitioned as separate, intact vesicles [87].
Although a vast array of Cdk1 substrates has been now
characterized, the participation of Rab4 phosphorylation to
the control of the endosomal compartment during mitosis has
been now well established. Rab4 is indeed a small GTPase
associated with early endosomes [88], specifically phos-
phorylated by Cdk1 [89]. Upon phosphorylation, Rab4 is
redistributed to the cytoplasm, its dissociation from the
membranes probably contributing to the arrest of fusion
events among the structures of the early endocytic compart-
ment [89–92]. Supporting the observation that Rab4 is
phosphorylated in mitosis by Cdk1, this GTPase also
interacts with Pin1 [93] a sequence-specific and phosphor-
ylation-dependent peptidyl-prolyl cis-trans isomerase that
recognize phosphorylated Ser/Thr-Pro sequences specifi-
cally present in mitotic phosphoproteins [94], among which
Cdc25, Wee1, Myt1, Plk1 and Cdc27 [95].
Although distribution of vesiculated organelles, including
early endosomes, is basically a random process, it still requiresTable 1
Rab proteins involved in signaling pathways
Rab Rab function
Rab2 Early secretory vescicles
Rab4 Early/recycling endosomes
Rab5 Early endosomes
Rab7 Late endsomes
Rab8 TGN-plasma membrane
Rab11 Perinuclar recycling endosomes plasma membrane-Golgi traffic
Rab13 Tight junction formation
Rab23
Rab25
Rab32association of these structures with the cytoskeleton for an
ordered partitioning [87]. Indeed, also during interphase, actin
participates to all endocytic steps, from internalization at the
plasma membrane [96], to trafficking through the cytoplasm
[97], fusion of phagosomes with early endosomes [98], and
transport from early to late endosomes [99,100]. A role for
Rab5 in coordinating the actin cytoskeleton with the early
endosome compartment is recently emerging [101,102].
Interestingly, a Rab5 isoform, Rab5b, is also phosphorylated
by Cdk1 [103] and, although these represent in vitro
observations, they suggest a role for phosphorylation of this
GTPases in the control of the physical organization of the
early endocytic compartment during mitosis.
Structures such as the Golgi apparatus need to undergo
fragmentation to be uniformly distributed among daughter
cells (see [104] for a review). As the small GTPase Rab1 is
required for vesicular traffic from the ER to the cis-Golgi
compartment, and for transport between the cis and medial
compartments of the Golgi stack [105] and Cdk1 also
phosphorylates Rab1 at the onset of mitosis [89], such
phosphorylation and the consequent preferential distribution
of Rab1 to the cytoplasm [89] may strongly contribute to
Golgi fragmentation typical of mitosis [104].
Phosphorylation as a mechanism to control the function
of Rab proteins has been proposed for other members of this
family of GTPases (Table 2). Although confirmations for
these observations and their organization in a comprehen-
sive model are still awaited, they deserve to be cited.
Thrombin, a potent inducer of the release of secretory
granules in platelets and, therefore, a model system for the
study of exocytosis, readily induces phosphorylation of
Rab3B, Rab6 and Rab8 [106]. No information is still
available about the kinases responsible and the nature of
such phosphorylation (tyrosine, serine or threonine).
Besides being a substrate for Cdk1 (see above), Rab4 has
been also demonstrated as in vitro substrate for Erk1 [107].
In this regard it is anyway important to note that Erk1 and
Cdk1 are both members of the proline-directed family of
serine/threonine kinases, therefore sharing a similar minimal
consensus of substrate phosphorylation. In vivo confirma-
tion will therefore be important to properly evaluate a roleInteracting partner Signaling pathway
PKCL/E PKC
P13K/Akt
hVPS34/p150
p85a/p110h Akt
APPL1 e APPL2 Nucleosome remodeling
hVPS34/p150
Germinal center kinase (GCK) MAP kinase (JNK)
P14Kh
PKA PKA
Sonic hedgehog
P13K/Akt
PKA PKA
Table 2
Proposed phosphorylated members of the Rab family of GTPases
Kinase Rab substrate Reference
Cdk1 Rab4 (Bailly et al., [89])
Rab1 (Bailly et al., [89])
Rab5b (Chiariello et al., [103])
Erk1 Rab4 (Cormont et al., [107])
Rab5a (Chiariello et al., [103])
? Rab3B (Karniguian et al., [106])
Rab6 (Karniguian et al., [106])
Rab8 (Karniguian et al., [106])
Src-family kinase? Rab24 (Ding et al., [109])
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translational modification. Nonetheless, in a comparative
approach, we have demonstrated that even in vitro, these
two proline-directed Ser/Thr kinases, Cdk1 and Erk1, are
able to specifically recognize different Rab5 isoforms [103].
In addition, we also show that Erk1 and Cdk1 are able to
discriminate a very similar consensus motif in Rab5a,
Rab5b and Rab5c [103], suggesting that these proteins,
whose functions and characteristics are otherwise indistin-
guishable [108], may represent alternative ways for a cell to
control early steps in the endocytic process, in response to
the activation of different kinases.
Finally, tyrosine phosphorylation at multiple sites of
Rab24 has been recently reported and correlated to the
activity of the Src family of non-receptor tyrosine kinases
[109]. Though, as these experiments are exclusively based
on the overexpression of the GTPase, a confirmation that
also the endogenous protein is a substrate for this kind of
modification is currently awaited.10. Conclusions
Recent findings have provided insights into the signaling
properties of different family of the RAS superfamily of
small GTPases. The data available so far on some Rab
family members demonstrate that their function is intimately
connected with signal transduction (Tables 1 and 2). Indeed,
several Rab proteins appear to exert their function through
the activation of signaling cascades that are involved in
various cell functions. It has been demonstrated that a single
Rab protein, also through the action of different downstream
effector proteins, is able to activate different biological
responses. Although still fragmentary, information currently
available finally represent a solid ground to establish a role
for most, if not all, Rab proteins in the modulation of
intracellular signaling pathways.Aknowledgements
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